Literature DB >> 25190007

Iontophoretic transdermal sampling of iohexol as a non-invasive tool to assess glomerular filtration rate.

Asma Djabri1, William van't Hoff, Penelope Brock, Ian C K Wong, Richard H Guy, M Begoña Delgado-Charro.   

Abstract

PURPOSE: To explore the potential of non-invasive reverse iontophoresis transdermal extraction of iohexol as a marker of glomerular filtration rate.
METHODS: A series of in vitro experiments were undertaken to establish the feasibility of iohexol reverse iontophoresis and to determine the optimal conditions for the approach. Subsequently, a pilot study in paediatric patients was performed to provide proof-of-concept.
RESULTS: The iontophoretic extraction fluxes of iohexol in vitro were proportional to the marker subdermal concentration and the reverse iontophoretic technique was able to track changes dynamically in simulated pharmacokinetic profiles. Reverse iontophoresis sampling was well tolerated by the four paediatric participants. The deduced values of the iohexol terminal elimination rate constant from transdermal reverse iontophoresis sampling agreed with those estimated by conventional blood sampling.
CONCLUSIONS: Reverse iontophoretic transdermal extraction fluxes mirrored the subdermal concentration profiles of iohexol, a relatively large neutral marker of glomerular filtration both in vitro and in vivo. The efficiency of extraction in vivo was well predicted by the in vitro model used.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25190007     DOI: 10.1007/s11095-014-1488-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  33 in total

Review 1.  Reverse iontophoresis for non-invasive transdermal monitoring.

Authors:  Benoît Leboulanger; Richard H Guy; M Begoña Delgado-Charro
Journal:  Physiol Meas       Date:  2004-06       Impact factor: 2.833

2.  Simultaneous extraction of urea and glucose by reverse iontophoresis in vivo.

Authors:  Anke Sieg; Richard H Guy; M Begoña Delgado-Charro
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

3.  Use of the GlucoWatch biographer in children with type 1 diabetes.

Authors:  H Peter Chase; Mary D Roberts; Clare Wightman; Georgeanna Klingensmith; Satish K Garg; Michelle Van Wyhe; Shashi Desai; Wesley Harper; Margarita Lopatin; Miroslaw Bartkowiak; Janet Tamada; Richard C Eastman
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

Review 4.  Accurate and feasible measurements of GFR--is the iohexol clearance the answer?

Authors:  M Aurell
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

5.  Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling.

Authors:  Benoît Leboulanger; Marc Fathi; Richard H Guy; M Begoña Delgado-Charro
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

6.  Assessment of the "skin reservoir" of urea by confocal Raman microspectroscopy and reverse iontophoresis in vivo.

Authors:  Valentine Wascotte; Peter Caspers; Johanna de Sterke; Michel Jadoul; Richard H Guy; Véronique Préat
Journal:  Pharm Res       Date:  2007-05-12       Impact factor: 4.200

7.  Comparative evaluation of iohexol and inulin clearance for glomerular filtration rate determinations.

Authors:  H G Lindblad; U B Berg
Journal:  Acta Paediatr       Date:  1994-04       Impact factor: 2.299

Review 8.  Measurement and estimation of GFR in children and adolescents.

Authors:  George J Schwartz; Dana F Work
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-09       Impact factor: 8.237

9.  Reverse iontophoresis for noninvasive glucose monitoring: the internal standard concept.

Authors:  Anke Sieg; Richard H Guy; M Begoña Delgado-Charro
Journal:  J Pharm Sci       Date:  2003-11       Impact factor: 3.534

10.  Noninvasive glucose monitoring by reverse iontophoresis in vivo: application of the internal standard concept.

Authors:  Anke Sieg; Richard H Guy; M Begoña Delgado-Charro
Journal:  Clin Chem       Date:  2004-05-20       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.